The vaccine division of Sanofi Pasteur has reported their expectations of being able to release their new Dengue vaccine in 2012. The vaccine has been in human trials as reported by medicalnewstoday.com Read more at: Sanofi Pasteur Dengue Vaccine Enters Pediatric Efficacy Clinical Study

ABC news reported in January 2010 that Acuvax Ltd, an Australian company has started the first round of human trials of a new Dengue Vaccine in the United States. The vaccine reportedly uses proteins found in the dengue virus to trigger an immune response. Read more at: http://www.abc.net.au/news/stories/2010/01/27/2802344.htm http://www.acuvax.com.au/assets/hawaii-biotech-inc.html